SARAH ATKINS: Open Payments
NPI 1871139394 · CONWAY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,006 in 132 payments from 14 companies in 2025. Trend: 2023 $2,721 · 2024 $3,403 · 2025 $2,006
Food & beverage: $2,006
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $592 |
| Aimmune Therapeutics, Inc. | 21 | $313 |
| Janssen Biotech, Inc. | 16 | $237 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 21 | $215 |
| Gilead Sciences, Inc. | 5 | $135 |
| Ipsen Biopharmaceuticals, Inc | 5 | $93 |
| Regeneron Healthcare Solutions, Inc. | 3 | $90 |
| Phathom Pharmaceuticals, Inc. | 11 | $88 |
| Madrigal Pharmaceuticals | 3 | $87 |
| QOL Medical, LLC | 3 | $56 |
Products named: ZENPEP, TREMFYA, RINVOQ, XIFAXAN, LINZESS, SKYRIZI, DUPIXENT, VOQUEZNA.
Industry payments across AR — which companies pay providers there.
